Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Archives

You are currently viewing the 2009 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: DIFFERIN

« Back to Dashboard

Summary for Tradename: DIFFERIN

Patents:3
Applicants:1
NDAs:4
Suppliers: see list6

Pharmacology for Tradename: DIFFERIN

Ingredient-typeRetinoids
Drug ClassRetinoid

Clinical Trials for: DIFFERIN

Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne
Status: Completed Condition: Acne Vulgaris

A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging
Status: Recruiting Condition: Photoaging; Photodamage

Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
Status: Completed Condition: Skin Manifestations

Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin
Status: Completed Condition: Skin Manifestations

An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne
Status: Active, not recruiting Condition: Acne

A Pilot Study to Evaluate The Efficacy of Adapalene 0.3% for Use in the Prevention and Treatment of Senile Purpura
Status: Recruiting Condition: Senile Purpura

Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne
Status: Completed Condition: Acne Vulgaris

A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne
Status: Completed Condition: Acne Vulgaris

Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris
Status: Completed Condition: Acne

Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin
Status: Completed Condition: Acne Vulgaris

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Galderma Labs Lp
DIFFERIN
adapalene
SOLUTION; TOPICAL020338May 31, 1996DISCNNoRE34440<disabled><disabled>
Galderma Labs Lp
DIFFERIN
adapalene
GEL; TOPICAL021753Jun 19, 2007RXYesRE34440<disabled><disabled>
Galderma Labs Lp
DIFFERIN
adapalene
GEL; TOPICAL021753Jun 19, 2007RXYes<disabled><disabled>
Galderma Labs Lp
DIFFERIN
adapalene
CREAM; TOPICAL020748May 26, 2000RXYes4,717,720<disabled><disabled>
Galderma Labs Lp
DIFFERIN
adapalene
SOLUTION; TOPICAL020338May 31, 1996DISCNNo4,717,720<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: DIFFERIN

Drugname Dosage Strength RLD Submissiondate
adapaleneTopical Gel0.30%Differin9/15/2009
« Back to Dashboard

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: PatentStatBiotechBlogJournal of Commercial Biotechnology

`abc